Company profile

HCW Biologics Inc. Insider Trading

HCWB

Every SEC Form 4 insider trading filing for HCW Biologics Inc. (HCWB) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0001828673
Filings
50
Insiders
8
Last filing
2026-07-29

Activity summary

Recent insider activity is bullish. Over the last 30 days, 3 insiders purchased shares (net $100K). Buying was led by Wong Hing C.

Three year balance

Buy and sell value by quarter, Q2 23 to Q3 26. HCW Biologics Inc. insiders are net buyers across the period shown.

Q2 23Q3 23Q4 23Q1 24Q2 24Q2 25Q2 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $3.0M.

90 day insight

Over the last 90 days, HCW Biologics Inc. insiders bought $100K across 3 transactions with no open-market sales.

  • Most active insider: Wong Hing C with 1 transaction totaling $60K.
  • Largest single purchase: $60K by Wong Hing C on Jul 29, 2026.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jul 29, 2026Garrett Scott THCWB
Purchase
7,736$2.58$20K
Jul 29, 2026Flowers LeeHCWB
Purchase
7,736$2.58$20K
Jul 29, 2026Wong Hing CHCWB
Purchase
23,210$2.58$60K
May 22, 2026Garrett Scott THCWB
Purchase
177,936
May 22, 2026Garrett Scott THCWB
Purchase
177,936$1.41$250K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=HCWB" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Wong Hing CChief Executive Officer6 filings+$3.7M
Byam RebeccaChief Financial Officer6 filings+$1.3M
Garrett Scott TDirector5 filings+$710K
Flowers LeeSVP of Business Development4 filings+$146K
Greene Rick S.Director2 filings+$75K

Institutional Ownership

Top 13F-HR holders of HCW Biologics Inc. as of 2026-06-30

— stable
Total reported AUM
$8,328
QoQ change
Reporting period
2026-06-30
#1
Golden State Wealth Management, LLC
CIK 0001776033
$8,318
2K shares
#2
Caitong International Asset Management Co., Ltd
CIK 0001963355
$10
11 shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →